A highly accomplished leader, Mr. Rosconi has more than 30 years experience in the pharmaceutical industry in Canada and internationally. Equally comfortable in small and large organizations, his experience covers the full gamut of activities in the biotechnology industry – drug development, product licensing, market access management, government relations, and sales and marketing – as well as providing direction and strategic planning.

During his years at Theratechnologies, Mr. Rosconi made it his mission to complete the various stages of the clinical trials for tesamoreline, as well as the regulatory process in the United States for acceptance. He also played an important role in the conclusion of a partnership for the exclusive rights for the commercialization of tesamoreline in the U.S.

Mr. Rosconi’s contribution to the biotechnology industry is not limited to his achievements at Theratechnologies. He has given his expertise and strategic planning skills to help BioQuebec thrive as an organization and was elected President of the Board of Directors for more than two years. He was also on the Board of BIOTECanada, Rx&D and Montreal InVivo, and on the boards of the following companies: Ulysses Pharmaceuticals, Minstal Pharma, Milestone Pharma, Cardio Metabolics and Otsuka Canada Pharmaceutical.

Yves Rosconi is a passionate man with exceptional human qualities. Throughout his career, he has shared his knowledge and expertise in the life sciences industry, contributing to a better quality of life for all in Canada as well as abroad.